Vaccines and vaccination against tick-borne encephalitis

Expert Review of Vaccines

Volumn 11, Issue 9, 2012, Pages 1103-1119

  Kollaritsch, Herwig ^a   Paulke Korinek, Maria ^a   Holzmann, Heidemarie ^b   Hombach, Joachim ^c   Bjorvatn, Bjarne ^d   Barrett, Alan ^e  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d UNIVERSITY OF BERGEN   (Norway)

^e University of Texas Medical Branch School of Medicine   (United States)

Author keywords

epidemiology; long term protection; prophylaxis; tick borne encephalitis; vaccination; vaccines

Indexed keywords

BOVINE SERUM ALBUMIN; CYCLOPHOSPHAMIDE; ENCEVIR; FLUOROURACIL; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 6; JAPANESE ENCEPHALITIS VACCINE; METHOTREXATE; TBE MOSCOW VACCINE; TICK BORNE ENCEPHALITIS VACCINE; TICOVAC; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANTIBODY TITER; ARTHRALGIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; DIARRHEA; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG IMPURITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EMBRYO CELL; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FATIGUE; FEVER; FLU LIKE SYNDROME; HEADACHE; HIGH RISK POPULATION; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOPATHOGENESIS; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INJECTION SITE SWELLING; IXODES RICINUS; LYMPHADENOPATHY; MALAISE; MEDICAL PRACTICE; MYALGIA; NAUSEA; NECK PAIN; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROCONVERSION; SHELF LIFE; SOMNOLENCE; TICK; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VACCINATION; VACCINATION REACTION; VERTIGO; VIREMIA; VIRUS DIAGNOSIS; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; VOMITING; WORLD HEALTH ORGANIZATION;

ANIMALS; CLINICAL TRIALS AS TOPIC; ENCEPHALITIS, TICK-BORNE; HUMANS; VACCINATION; VIRAL VACCINES; ZOONOSES;

EID: 84869435167     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.12.86     Document Type: Review

References (132)

1. Holzmann H, Aberle SW, Stiasny K et al . Tick-borne encephalitis from eating goat cheese in a mountain region of Austria. Emerging Infect. Dis. 15 (10), 1671- 1673 (2009).
2. World Health Organization . Vaccines against tick-borne encephalitis: WHO position paper . WER 24 (86), 241- 256 (2011).
3. Suess J . Tick borne encephalitis 2010: Epidemiology, risk areas and virus strains in Europe and Asia- An overview . Ticks Tick. Borne. Dis. 2 (1), 2- 15 (2011).
4. Barrett P, Plotkin S, Ehrlich H . Tick borne encephalitis virus vaccines . In: Vaccines . Plotkin S, Orenstein W, Offi t P (Eds). Saunders Elsevier, PA, USA, 841- 856 (2008).
5. Gritsun TS, Lashkevich VA, Gould EA . Tick-borne encephalitis. Antiviral Res. 57 (1-2), 129- 146 (2003).
6. Mansfi eld KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, Solomon T . Tick-borne encephalitis virus- A review of an emerging zoonosis. J. Gen. Virol. 90 (PT8), 1781- 1794 (2009).
7. Waldenstrom J, Lundkvist A, Falk KI et al . Migrating birds and tickborne encephalitis virus . Emerg. Infect. Dis. 13 (8), 1215- 1218 (2007).
8. Kriz B, Benes C, Danielová V, Daniel M . Socio-economic conditions and other anthropogenic factors infl uencing tick-borne encephalitis incidence in the Czech Republic. Int. J. Med. Microbiol. 293 (SUPPL37), 63- 68 (2004).
9. Sumilo D, Asokliene L, Avsic-Zupanc T et al . Behavioural responses to perceived risk of tick-borne encephalitis: Vaccination and avoidance in the Baltics and Slovenia. Vaccine 26 (21), 2580- 2588 (2008).
10. Randolph SE . To what extent has climate change contributed to the recent epidemiology of tick-borne diseases? Vet. Parasitol. 167 (2-4), 92- 94 (2010).
11. Randolph SE; EDEN-TBD sub-project team . Human activities predominate in determining changing incidence of tick-borne encephalitis in Europe. Euro. Surveill. 15 (27), 24- 31 (2010).
12. Kaiser R . The clinical and epidemiological profi le of tick-borne encephalitis in southern Germany 1994-98: A prospective study of 656 patients. Brain 122 (PT11), 2067- 2078 (1999).
13. Heinz FX, Holzmann H, Essl A, Kundi M . Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 25 (43), 7559- 7567 (2007).
14. Demicheli V, Debalini MG, Rivetti A . Vaccines for preventing tick-borne encephalitis. Cochrane Database Syst. Rev. (1) , CD000977 (2009).
15. Heinz F, Stiasny K . Flaviviren . In: Medizinische Virologie . Doerr H, Gerlich W (Eds). Georg Thieme, Stuttgart, Germany, 380- 386 (2010).
16. Ecker M, Allison SL, Meixner T, Heinz FX . Sequence analysis and genetic classifi cation of tick-borne encephalitis viruses from Europe and Asia. J. Gen. Virol. 80 (PT1), 179- 185 (1999).
17. Grard G, Moureau G, Charrel RN et al . Genetic characterization of tick-borne fl aviviruses: New insights into evolution, pathogenetic determinants and taxonomy. Virology 361 (1), 80- 92 (2007).
18. Heinz FX . Epitope mapping of fl avivirus glycoproteins. Adv. Virus Res. 31, 103- 168 (1986).
19. Danielová V, Holubová J, Pejcoch M, Daniel M . Potential signifi cance of transovarial transmission in the circulation of tick-borne encephalitis virus. Folia Parasitol. 49 (4), 323- 325 (2002).
20. Kaiser R . Tick-borne encephalitis. Infect. Dis. Clin. North Am. 22 (3), 561- 575 (2008).
21. Donoso Mantke O, Escadafal C, Niedrig M, Pfeffer M ; Working Group For Tick-Borne Encephalitis Virus C . Tick-borne encephalitis in Europe, 2007 to 2009. Euro. Surveill. 16 (39) , pii: 19976 (2011).
22. Lindquist L, Vapalahti O . Tick-borne encephalitis. Lancet 371 (9627), 1861- 1871 (2008).
23. Petri E, Gniel D, Zent O . Tick-borne encephalitis (TBE) trends in epidemiology and current and future management. Travel Med. Infect. Dis. 8 (4), 233- 245 (2010).
24. Suess JA . Protecting our antibiotic lifeline, Part II. Mich. Med. 102 (5), 25 (2003).
25. Ko S, Kang JG, Kim SY et al . Prevalence of tick-borne encephalitis virus in ticks from southern Korea. J. Vet. Sci. 11 (3), 197- 203 (2010).
26. Lukan M, Bullova E, Petko B . Climate warming and tick-borne encephalitis, Slovakia. Emerging Infect. Dis. 16 (3), 524- 526 (2010).
27. Briggs BJ, Atkinson B, Czechowski DM et al . Tick-borne encephalitis virus, Kyrgyzstan. Emerging Infect. Dis. 17 (5), 876- 879 (2011).
28. Suess J . Tick-borne encephalitis in Europe and beyond the epidemiological situation as of 2007 . Euro. Surveill. 13 (26), 18916 (2008).
29. Demina TV, Dzhioev YP, Verkhozina MM et al . Genotyping and characterization of the geographical distribution of tick-borne encephalitis virus variants with a set of molecular probes. J. Med. Virol. 82 (6), 965- 976 (2010).
30. Kunze U . 15th ISW-TBE Newsletter. ISW TBE Working Group (2011).
31. Donoso Mantke O, Schädler R, Niedrig M . A survey on cases of tick-borne encephalitis in European countries. Euro Surveill. 13 (17) , pii: 18848 (2008).
32. Onischenko GG, Fedorov YM, Paksina ND . Surveillance of tick-borne encephalitis and activity for its prophylactic in Russian Federation. Russian . Vopr. Virusol. 52, 8- 10 (2007).
33. Han X, Juceviciene A, Uzcategui NY et al . Molecular epidemiology of tick-borne encephalitis virus in Ixodes ricinus ticks in Lithuania. J. Med. Virol. 77 (2), 249- 256 (2005).
34. Casati S, Gern L, Piffaretti JC . Diversity of the population of Tick-borne encephalitis virus infecting Ixodes ricinus ticks in an endemic area of central Switzerland (Canton Bern). J. Gen. Virol. 87 (PT8), 2235- 2241 (2006).
35. Dobler G, Zöller G, Poponnikova T, Gniel D, Pfeffer M, Essbauer S . Tick-borne encephalitis virus in a highly endemic area in Kemerovo (Western Siberia, Russia) . Int. J. Med. Microbiol. 298 (SUPPL1), 94- 101 (2008).
36. Haglund M, Günther G . Tick-borne encephalitis-pathogenesis, clinical course and long-term follow-up. Vaccine 21 (SUPPL1), S11- S18 (2003).
37. Dumpis U, Crook D, Oksi J . Tick-borne encephalitis. Clin. Infect. Dis. 28 (4), 882- 890 (1999).
38. Maximova OA, Faucette LJ, Ward JM, Murphy BR, Pletnev AG . Cellular infl ammatory response to fl aviviruses in the central nervous system of a primate host. J. Histochem. Cytochem. 57 (10), 973- 989 (2009).
39. Gelpi E, Preusser M, Garzuly F, Holzmann H, Heinz FX, Budka H . Visualization of Central European tick-borne encephalitis infection in fatal human cases. J. Neuropathol. Exp. Neurol. 64 (6), 506- 512 (2005).
40. Gelpi E, Preusser M, Laggner U et al . Infl ammatory response in human tick-borne encephalitis: Analysis of postmortem brain tissue. J. Neurovirol. 12 (4), 322- 327 (2006).
41. Holub M, Klucková Z, Beran O, Aster V, Lobovská A . Lymphocyte subset numbers in cerebrospinal fl uid: Comparison of tick-borne encephalitis and neuroborreliosis. Acta Neurol. Scand. 106 (5), 302- 308 (2002).
42. Atrasheuskaya AV, Fredeking TM, Ignatyev GM . Changes in immune parameters and their correction in human cases of tick-borne encephalitis. Clin. Exp. Immunol. 131 (1), 148- 154 (2003).
43. Toporkova MG, Aleshin SE, Ozherelkov SV, Nadezhdina MV, Stephenson JR, Timofeev AV . Serum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcome. Clin. Exp. Immunol. 152 (3), 517- 521 (2008).
44. Kerbo N, Donchenko I, Kutsar K, Vasilenko V . Tickborne encephalitis outbreak in Estonia linked to raw goat milk, May-June 2005. Euro Surveill. 10 (6) , E050623.2 (2005).
45. Cizman M, Rakar R, Zakotnik B, Pokorn M, Arnez M . Severe forms of tick-borne encephalitis in children. Wien. Klin. Wochenschr. 111 (12), 484- 487 (1999).
46. Schmolck H, Maritz E, Kletzin I, Korinthenberg R . Neurologic, neuropsychologic, and electroencephalographic fi ndings after European tick-borne encephalitis in children. J. Child Neurol. 20 (6), 500- 508 (2005).
47. Zenz W, Pansi H, Zoehrer B et al . Tick-borne encephalitis in children in Styria and Slovenia between 1980 and 2003. Pediatr. Infect. Dis. J. 24 (10), 892- 896 (2005).
48. Jones N, Sperl W, Koch J, Holzmann H, Radauer W . Tick-borne encephalitis in a 17-day-old newborn resulting in severe neurologic impairment. Pediatr. Infect. Dis. J. 26 (2), 185- 186 (2007).
49. Laursen K, Knudsen JD . Tick-borne encephalitis: A retrospective study of clinical cases in Bornholm, Denmark. Scand. J. Infect. Dis. 35 (5), 354- 357 (2003).
50. Mandl CW . Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis. V irus Res. 111 (2), 161- 174 (2005).
51. Bröker M, Kollaritsch H . After a tick bite in a tick-borne encephalitis virus endemic area: Current positions about post-exposure treatment. Vaccine 26 (7), 863- 868 (2008).
52. Arras C, Fescharek R, Gregersen JP . Do specifi c hyperimmunoglobulins aggravate clinical course of tick-borne encephalitis? Lancet 347 (9011), 1331 (1996).
53. Bröker M, Schöndorf I . Are tick-borne encephalitis vaccines interchangeable? Expert Rev. Vaccines 5 (4), 461- 466 (2006).
54. Pen'evskaia NA, Rudakov NV . [Effi ciency of use of immunoglobulin preparations for the postexposure prevention of tick-borne encephalitis in Russia (a review of semi-centennial experience)]. Med. Parazitol. (Mosk.) (1) , 53- 59 (2010).
55. Holzmann H . Diagnosis of tick-borne encephalitis. Vaccine 21 (SUPPL1), S36- S40 (2003).
56. Kaiser R, Holzmann H . Laboratory fi ndings in tick-borne encephalitis- correlation with clinical outcome. Infection 28 (2), 78- 84 (2000).
57. Klockmann U, Krivanec K, Stephenson JR, Hilfenhaus J . Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine. Vaccine 9 (3), 210- 212 (1991).
58. Holzmann H, Kundi M, Stiasny K et al . Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J. Med. Virol. 48 (1), 102- 107 (1996).
59. Pierson TC, Sánchez MD, Puffer BA et al . A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346 (1), 53- 65 (2006).
60. Loew-Baselli A, Poellabauer EM, Pavlova BG et al . Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: Review of a clinical development programme. Vaccine 29 (43), 7307- 7319 (2011).
61. Girgsdies OE, Rosenkranz G . Tick-borne encephalitis: Development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study. Vaccine 14 (15), 1421- 1428 (1996).
62. Zent O, Hennig R . Post-marketing surveillance of immediate allergic reactions: Polygeline-based versus polygeline-free pediatric TBE vaccine. Vaccine 23 (5), 579- 584 (2004).
63. Zent O, Bröker M . Tick-borne encephalitis vaccines: Past and present. Expert Rev. Vaccines 4 (5), 747- 755 (2005).
64. Vorob'eva MS, Rasshchepkina MN, Ladyzhenskaia IP . [Vaccines, immunoglobulins, and test systems for the prevention and diagnosis of tick-borne encephalitis]. Vopr. Virusol. 52 (6), 30- 36 (2007).
65. Vorob'eva MS, Rasshchepkina MN, Ladyzhenskaia IP, Gorbunov MA, Pavlova LI, Bektimirov TA . [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the 'Immuno' fi rm]. Vopr. Virusol. 41 (5), 221- 224 (1996).
66. Eidgenössische Kommission für Impffragen. Swiss Vaccination Schedule 2008. Guidelines and Recommendations (S VIII). Federal Offi ce of Public Health, Bern, Switzerland (2008).
67. Zent O, Hennig R, Banzhoff A, Bröker M . Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers. J. Travel Med. 12 (2), 85- 93 (2005).
68. Schöndorf I, Beran J, Cizkova D, Lesna V, Banzhoff A, Zent O . Tick-borne encephalitis (TBE) vaccination: Applying the most suitable vaccination schedule. Vaccine 25 (8), 1470- 1475 (2007).
69. Wittermann C, Schöndorf I, Gniel D . Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules. Vaccine 27 (10), 1661- 1666 (2009).
70. Rendi-Wagner P . Advances in vaccination against tick-borne encephalitis. Expert Rev. Vaccines 7 (5), 589- 596 (2008).
71. Zent O, Jilg W, Plentz A et al . Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule. Vaccine 21 (32), 4655- 4660 (2003).
72. Beran J, Douda P, Gniel D, Zent O . Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule. Int. J. Med. Microbiol. 293 (SUPPL37), 130- 133 (2004).
73. Rendi-Wagner P, Kundi M, Zent O et al . Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine 23 (4), 427- 434 (2004).
74. Rendi-Wagner P, Hoeller K, Kollaritsch H; Osterreichische Expertengruppe für Reisemedizin . [Immunization recommendations for travel in the Mediterranean area]. Wien. Klin. Wochenschr. 116 (19-20), 652- 660 (2004).
75. Plentz A, Jilg W, Schwarz TF, Kuhr HB, Zent O . Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults. Vaccine 27 (6), 853- 856 (2009).
76. Schoendorf I, Schoenfeld C, Nicolay U, Zent O, Banzhoff A . Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule . Int. J. Med. Microbiol. 296 (S1), 208- 212 (2006).
77. Pavlova LI, Gorbunov MA, Vorob'eva MS et al . [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents]. Zh. Mikrobiol. Epidemiol. Immunobiol. (6) , 50- 53 (1999).
78. Gorbunov MA, Noskova AV, El'shina GA et al . [Characteristics of 'Avaxim' hepatitis A vaccine produced by the fi rm 'Pasteur Merrier' (results of fi eld clinical trials)]. Vopr. Virusol. 45 (1), 39- 42 (2000).
79. Krasilnikov IV, Mischenko IA, Sharova OI et al . Vaccine 'EnceVir': Development in implementaiton in pracitcal use . Biopreparations 2 (14), 21- 24 (2004).
80. Stavitskaya IV, Shkuratova OV, Pavlova LI, Shutova NA, Sharova OI . Immunological effetiveness of EnceVir in children . Biopreparations 2 (14), 34- 36 (2004).
81. Leonova GN, Pavlenko EV . Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human. Vaccine 27 (21), 2899- 2904 (2009).
82. Schosser R, Kaiser R, Mansmann U, Heininger U . Seropositivity before and seroprotection after a booster vaccination with FSME-Immun adults in subjects with a time interval of >4,5 years since the last TBE vaccination . Presented at: International Jena Symposium on Tick Borne Diseases . Weimar, Germany, 19-21 March 2009.
83. Baumhackl U, Franta C, Retzl J, Salomonowitz E, Eder G. A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis. Vaccine 21 (SUPPL1), S56- S61 (2003).
84. Zent O, Banzhoff A, Hilbert AK, Meriste S, Sluzewski W, Wittermann Ch . Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Vaccine 21 (25-26), 3584- 3592 (2003).
85. Loew-Baselli A, Konior R, Pavlova BG et al .; FSME-IMMUN study group . Safety and immunogenicity of the modifi ed adult tick-borne encephalitis vaccine FSME-IMMUN: Results of two large phase 3 clinical studies. Vaccine 24 (24), 5256- 5263 (2006).
86. Rendi-Wagner P, Paulke-Korinek M, Kundi M, Wiedermann U, Laaber B, Kollaritsch H . Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up. Vaccine 25 (27), 5097- 5101 (2007).
87. Schoendorf I, Ternak G, Oroszlàn G, Nicolay U, Banzhoff A, Zent O . Tick-born encephalitis (TBE) vaccination in children: Advantage of the rapid immunization schedule (i.e., days 0, 7, 21). Hum. Vaccin. 3 (2), 42- 47 (2007).
88. Weinzettel R, Ertl S, Zwiauer K . [FSME monitoring: Monitoring of adverse events of tick-borne-encephalitis vaccines by selected paediatricians and general practitioners]. Wien. Med. Wochenschr. 157 (5-6), 107- 110 (2007).
89. Loew-Baselli A, Poellabauer EM, Pavlova BG et al . Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years. Hum. Vaccin. 5 (8), 551- 556 (2009).
90. Paulke-Korinek M, Rendi-Wagner P, Kundi M, Laaber B, Wiedermann U, Kollaritsch H . Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection. Vaccine 27 (50), 7027- 7030 (2009).
91. Pöllabauer EM, Fritsch S, Pavlova BG et al . Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine. Vaccine 28 (29), 4558- 4565 (2010).
92. Pöllabauer EM, Pavlova BG, Löw-Baselli A et al . Comparison of immunogenicity and safety between two paediatric TBE vaccines. Vaccine 28 (29), 4680- 4685 (2010).
93. Ehrlich HJ, Pavlova BG, Fritsch S et al . Randomized, phase II dose-fi nding studies of a modifi ed tick-borne encephalitis vaccine: Evaluation of safety and immunogenicity. Vaccine 22 (2), 217- 223 (2003).
94. Hainz U, Jenewein B, Asch E, Pfeiffer KP, Berger P, Grubeck-Loebenstein B . Insuffi cient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 23 (25), 3232- 3235 (2005).
95. Weinberger B, Keller M, Fischer KH et al . Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years . Vaccine 28 (20), 3511- 3515 (2007).
96. Stiasny K, Aberle JH, Keller M, Grubeck-Loebenstein B, Heinz FX . Age affects quantity but not quality of antibody responses after vaccination with an inactivated fl avivirus vaccine against tick-borne encephalitis. Plos One 7 (3), e34145 (2012).
97. Pavlova BG, Loew-Baselli A, Fritsch S et al . Tolerability of modifi ed tick-borne encephalitis vaccine FSME-IMMUN 'NEW' in children: Results of postmarketing surveillance. Vaccine 21 (7-8), 742- 745 (2003).
98. Wittermann C, Petri E, Zent O . Longterm persistence of tick-borne encephalitis antibodies in children 5 years after fi rst booster vaccination with Encepur Children. Vaccine 27 (10), 1585- 1588 (2009).
99. Krasilnikov I, Mischenko IA, Sharova OI, Vorob'eva M . Development of technology of tick-borne encephalitis vaccine (strain 205) . J. Med. Microbiol. 291 (SUPPL33), 173 (2002).
100. Pavlova LI, Stavitskaya IV, Gorbunov MA et al . Immunizations of children and adolescents with concentrated purifi ed vaccines against TBE . Biopreparations 1, 24- 28 (2003).
101. Romanenko VV, Esiunina MS, Kiliachina AS . [Experience in implementing the mass immunization program against tick-borne encephalitis in the Sverdlovsk Region]. Vopr. Virusol. 52 (6), 22- 25 (2007).
102. Borodina TN, Evtoushok GA, Tevelenok OG, Opeikina NN . Epidemiological effectiveness of vaccination against TBE in Krasnoyarsk region . Biopreparations 2 (14), 30- 31 (2004).
103. Il'chenko TE, Bilalova GP, Stavitskaya NX, Solanik RG, Bistritskaya LD, Krasnilikov IV . Organization of public health . Siberian J. Med. 2, 50- 55 (2009).
104. Lanzavecchia A, Bernasconi N, Traggiai E, Ruprecht CR, Corti D, Sallusto F . Understanding and making use of human memory B cells. Immunol. Rev. 211, 303- 309 (2006).
105. Andersson CR, Vene S, Insulander M, Lindquist L, Lundkvist A, Günther G . Vaccine failures after active immunisation against tick-borne encephalitis. Vaccine 28 (16), 2827- 2831 (2010).
106. Stiasny K, Holzmann H, Heinz FX . Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs. Vaccine 27 (50), 7021- 7026 (2009).
107. Holzmann H, Vorobyova MS, Ladyzhenskaya IP et al . Molecular epidemiology of tick-borne encephalitis virus: Cross-protection between European and Far Eastern subtypes. Vaccine 10 (5), 345- 349 (1992).
108. Chiba N, Osada M, Komoro K, Mizutani T, Kariwa H, Takashima I . Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization. Vaccine 17 (11-12), 1532- 1539 (1999).
109. Hayasaka D, Goto A, Yoshii K, Mizutani T, Kariwa H, Takashima I . Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains. Vaccine 19 (32), 4774- 4779 (2001).
110. Leonova GN, Ternovoi VA, Pavlenko EV, Maistrovskaya OS, Protopopova EV, Loktev VB . Evaluation of vaccine Encepur adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis virus. Vaccine 25 (5), 895- 901 (2007).
111. Fritz R, Orlinger KK, Hofmeister Y et al . Quantitative comparison of the crossprotection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes. Vaccine 30 (6), 1165- 1169 (2012).
112. Orlinger KK, Hofmeister Y, Fritz R et al . A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans. J. Infect. Dis. 203 (11), 1556- 1564 (2011).
113. Mansfi eld KL, Horton DL, Johnson N et al . Flavivirus-induced antibody cross-reactivity. J. Gen. Virol. 92 (PT12) , 2821- 2829 (2011).
114. Lobigs M, Diamond MS . Feasibility of cross-protective vaccination against fl aviviruses of the Japanese encephalitis serocomplex. Expert Rev. Vaccines 11 (2), 177- 187 (2012).
115. Ferenczi E, Bán E, Abrahám A et al . Severe tick-borne encephalitis in a patient previously infected by West Nile virus. Scand. J. Infect. Dis. 40 (9), 759- 761 (2008).
116. Schuller E, Klade CS, Heinz FX et al . Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51. Vaccine 26 (48), 6151- 6156 (2008).
117. Al-Safi ZA, Shavell VI, Gonik B . Vaccination in pregnancy. Womens Health (Lond. Engl.) 7 (1), 109- 119 (2011).
118. Wolf HM, Pum M, Jáger R, István L, Mannhalter JW, Eibl MM . Cellular and humoral immune responses in haemophiliacs after vaccination against tick-borne encephalitis. Br. J. Haematol. 82 (2), 374- 383 (1992).
119. Prelog M, Wilk C, Keller M et al . Diminished response to tick-borne encephalitis vaccination in thymectomized children. Vaccine 26 (5), 595- 600 (2008).
120. Hofmann H, Haschke F, Popow C, Götz M, Klabuschnigg A, Popow-Kraupp T . [Shortening of interval between fi rst and second TBE vaccination in asthmatic children]. Wien. Klin. Wochenschr. 93 (11), 358- 360 (1981).
121. Zielinski CC, Stuller I, Dorner F, Pötzi P, Müller C, Eibl MM . Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy. Cancer 58 (8), 1648- 1652 (1986).
122. Panasiuk B, Prokopowicz D, Panasiuk A . Immunological response in HIV-positive patients vaccinated against tick-borne encephalitis. Infection 31 (1), 45- 46 (2003).
123. Fischer M, Gibney K, MacNeil A . Tickborne encephalitis . In: Traveler's Health- Yellow Book . Oxford University Press, GA, USA (2011).
124. Kollaritsch H, Chmelík V, Dontsenko I et al . The current perspective on tick-borne encephalitis awareness and prevention in six Central and Eastern European countries: Report from a meeting of experts convened to discuss TBE in their region. Vaccine 29 (28), 4556- 4564 (2011).
125. Kunze U; ISW TBE . Tick-borne encephalitis: New paradigms in a changing vaccination environment. Wien. Med. Wochenschr. 161 (13-14), 361- 364 (2011).
126. Lundkvist A, Wallensten A, Vene S, Hjertqvist M . Tick-borne encephalitis increasing in Sweden, 2011. Euro Surveill. 16 (39) , pii: 19981 (2011).
127. Karaban I, Vedenkov A, Yashkova S, Sebut N . Epidemiology of tick-borne encephalitis and Lyme disease in the Republic of Belarus, 1998-2007 . EpiNorth, 10 (2), 48- 57 (2009).
128. Fomsgaard A, Christiansen C, Bodker R . First identifi cation of tick-borne encephalitis in Denmark outside of Bornholm, August 2009. Euro Surveill. 14 (36) , pii: 19325 (2009).
129. Pavlidou V, Geroy S, Diza E, Antoniadis A, Papa A . Epidemiological study of tick-borne encephalitis virus in northern Greece. Vector Borne Zoonotic Dis. 7 (4), 611- 615 (2007).
130. Lu Z, Bröker M, Liang G . Tick-borne encephalitis in mainland China. Vector Borne Zoonotic Dis. 8 (5), 713- 720 (2008).
131. Khastantinov M, Tserennorov D, Nymadavaa P et al . Tick-borne encephalitis in Mongolia . Presented at: 14th International Congress on Infectious Diseases . Miami, FL, USA, 9-12 March 2010 (Abstract 76.005, e372).
132. Walder G, Lkhamsuren E, Shagdar A et al . Serological evidence for tick-borne encephalitis, borreliosis, and human granulocytic anaplasmosis in Mongolia. Int. J. Med. Microbiol. 296 (SUPPL40), 69- 75 (2006).